Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Ischemic Stroke Companies

several pharmaceutical and medical technology companies were actively involved in the research, development, and production of products related to ischemic stroke. These companies focused on medications, therapies, and devices aimed at preventing, treating, or managing ischemic strokes, which occur when blood flow to the brain is blocked.

Latest Ischemic Stroke Companies Update:

Royal Philips Showcases Latest Technologies at Stroke Conferences: In October 2023, Philips presented advanced imaging solutions and robotic platforms designed to streamline diagnosis and treatment during the crucial "golden hour" after an ischemic stroke

Stryker's Trevo™ Retriever Earns European Approval for Large Vessel Blockages: This January 2024 milestone expands access to a potentially life-saving mechanical thrombectomy device across Europe for patients with complex clots.

Positive Phase 2 Results for AstraZeneca's ASP7378: This December 2023 study suggests the potential of ASP7378 for protecting brain tissue after an ischemic stroke, paving the way for further research and development.

Regen Therapeutics Initiates Phase 3 Trial for Stroke Recovery Stem Cell Therapy: This January 2024 development marks a significant step towards potentially improving functional outcomes in stroke patients through regenerative medicine.

Brainomix Secures FDA Marketing Authorization for e-Stroke Score: This November 2023 approval enables healthcare professionals to utilize this AI-powered platform for rapid stroke diagnosis and treatment decision support.

List of Ischemic Stroke Key companies in the market

GlaxoSmithKline plc (U.K)

Eli Lilly and Company (U.S.)

Pfizer Inc. (U.S.)

Bristol-Myers Squibb (U.S.)

Switzerland) Inc. (U.S.)

Johnson & Johnson Services Inc. (U.S.)

Ischemic Stroke Market Highlights:

Ischemic Stroke Market Size

Ischemic Stroke Market Trends

Ischemic Stroke Market Analysis

Ischemic Stroke Market Share

Ischemic Stroke Market Highlights:

Ischemic Stroke Market Trends

Ischemic Stroke Market Analysis

Ischemic Stroke Market Share

Ischemic Stroke Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.